Skip to main content

Table 3 Risk factors associated with ESI in HBV-ACLF patients

From: A novel imaging index for predicting adverse progression in acute-on-chronic liver failure related to hepatitis B virus: the low erector spine index

Parameters

Univariate analysis

 

Multivariate analysis

OR

95% CI

P value

OR

95% CI

P value

Age, per year

1.01

0.97–1.07

0.566

   

Gender (male vs. female‡)

1.33

0.27–6.56

0.723

   

Bilirubin, per 1 mg/dl

1.03

0.96–1.11

0.372

   

Albumin, per 1 g/L

0.89

0.78–1.01

0.076

   

Creatinine, per 1 µmol/L

1.01

0.98–1.04

0.520

   

INR, per 1 unit

0.84

0.48–1.47

0.543

   

ALT, per 1 U/L

1.00

1.00–1.00

0.223

   

AST, per 1 U/L

1.00

1.00–1.00

0.597

   

GGT, per 1 U/L

1.00

0.99–1.01

0.673

   

Hemoglobin, per 1 g/L

0.99

0.97–1.02

0.557

   

Serum Ammonia, per 1 mmol/L

0.99

0.96–1.01

0.986

   

Hepatic encephalopathy (yes vs.no‡)

4.17

1.15–5.04

0.029

2.26

2.05–3.18

0.006

Sepsis (yes vs.no‡)

0.90

0.30–2.69

0.850

   

SBP (yes vs.no‡)

2.87

0.99–8.37

0.053

3.95

1.01–5.46

0.037

Ascites (yes vs.no‡)

1.60

0.61–2.24

0.127

   

Respiratory infections (yes vs.no‡)

1.24

0.40–3.83

0.711

   

Kidney dysfunction (yes vs.no‡)

3.11

1.06–9.18

0.040

4.47

1.02–9.64

0.032

MELD, per 1 unit

1.01

0.98–1.23

0.794

   

MELD-Na, per 1 unit

1.01

0.95–1.06

0.835

   
  1. ‡: reference value. Abbreviations. OR: odds ratio, CI: confidence interval, INR: international normalized ratio, ALT: alanine transaminase, AST: aspartate transaminase, GGT: γ-glutamyl transferase, HE: hepatic encephalopathy, SBP: spontaneous bacterial peritonitis, MELD: model for end-stage liver disease, MELD-Na: MELD-Sodium.